IMMUNEWALK THERAPEUTICS Trademark

Trademark Overview


On Thursday, November 2, 2023, a trademark application was filed for IMMUNEWALK THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the IMMUNEWALK THERAPEUTICS trademark a serial number of 98252420. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 1, 2024. This trademark is owned by ImmuneWalk Therapeutics Inc.. The IMMUNEWALK THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the prevention and treatment of immune system diseases and disorders, central nervous system disorders, chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, Inflammatory kidney diseases, inflammatory bowel disease, rheumatoid arthritis, inflammatory pulmonary disease, atherosclerosis, infectious diseasesĀ and disorders, chronic inflammatory disease, and cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for immune system diseases and disorders, central nervous system disorders, chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, inflammatory kidney diseases, inflammatory bowel disease, rheumatoid arthritis, inflammatory pulmonary disease, atherosclerosis, infectious diseases and disorders, chronic inflammatory disease, and cancer; Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for regulating immune response; Nutritio...

Research and development in the pharmaceutical, biopharmaceutical, and biotechnology fields; research and development of pharmaceutical preparations and medicines; medical and scientific research services; pharmaceutical and biopharmaceutical product evaluation; consulting in the field of pharmaceutical, biopharmaceutical, and biotechnology research; testing of pharmaceuticals; scientific laboratory services and medical research laboratory services.
immunewalk therapeutics

General Information


Serial Number98252420
Word MarkIMMUNEWALK THERAPEUTICS
Filing DateThursday, November 2, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of immune system diseases and disorders, central nervous system disorders, chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, Inflammatory kidney diseases, inflammatory bowel disease, rheumatoid arthritis, inflammatory pulmonary disease, atherosclerosis, infectious diseasesĀ and disorders, chronic inflammatory disease, and cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for immune system diseases and disorders, central nervous system disorders, chronic inflammatory diseases, autoimmune diseases, chronic liver diseases, inflammatory kidney diseases, inflammatory bowel disease, rheumatoid arthritis, inflammatory pulmonary disease, atherosclerosis, infectious diseases and disorders, chronic inflammatory disease, and cancer; Chemical, pharmaceutical, biopharmaceutical and biomedical agents for medical use, namely, pharmaceutical agents for regulating immune response; Nutritional and dietary supplements for immune system support
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesResearch and development in the pharmaceutical, biopharmaceutical, and biotechnology fields; research and development of pharmaceutical preparations and medicines; medical and scientific research services; pharmaceutical and biopharmaceutical product evaluation; consulting in the field of pharmaceutical, biopharmaceutical, and biotechnology research; testing of pharmaceuticals; scientific laboratory services and medical research laboratory services.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 20, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 20, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmuneWalk Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPearl River, NY 10965

Party NameImmuneWalk Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPearl River, NY 10965

Trademark Events


Event DateEvent Description
Thursday, June 13, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 13, 2024NON-FINAL ACTION WRITTEN
Monday, August 26, 2024EXAMINER'S AMENDMENT ENTERED
Monday, August 26, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, August 26, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 26, 2024EXAMINERS AMENDMENT E-MAILED
Monday, August 26, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 1, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, June 13, 2024NON-FINAL ACTION E-MAILED
Monday, November 6, 2023NEW APPLICATION ENTERED
Monday, November 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 13, 2024ASSIGNED TO EXAMINER